Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Valenta
S Vrtala

Allergy

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Allergy|October 26, 1999
Recombinant allergens for specific immunotherapyR Valenta, S Vrtala
Allergy|August 5, 1998
Recombinant allergensR Valenta, S Vrtala, S Laffer, et al.
Allergy|September 4, 2013
An assay that may predict the development of IgG enhancing allergen-specific IgE binding during birch immunotherapyR Selb, J Eckl-Dorna, S Vrtala, et al.
Allergy|February 14, 2008
From allergen genes to new forms of allergy diagnosis and treatmentS Vrtala
Allergy|January 18, 2006
The role of Foxp3+ T cells in long-term efficacy of prophylactic and therapeutic mucosal tolerance induction in miceB Winkler, K Hufnagl, A Spittler, et al.
Allergy|July 26, 2017
House dust mites as potential carriers for IgE sensitization to bacterial antigensS Dzoro, I Mittermann, Y Resch-Marat, et al.
Allergy|August 14, 2002
Recombinant allergen-based concepts for diagnosis and therapy of type I allergyR Valenta
Allergy|January 11, 2018
Similar localization of conformational IgE epitopes on the house dust mite allergens Der p 5 and Der p 21 despite limited IgE cross-reactivityM Curin, T Garmatiuk, Y Resch-Marat, et al.
Allergy|February 21, 2012
Carrier-bound nonallergenic Der p 2 peptides induce IgG antibodies blocking allergen-induced basophil activation in allergic patientsK-W Chen, M Focke-Tejkl, K Blatt, et al.
Allergy|January 10, 2018
Isolation of a high-affinity Bet v 1-specific IgG-derived ScFv from a subject vaccinated with hypoallergenic Bet v 1 fragmentsE Gadermaier, K Marth, C Lupinek, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Allergy|October 26, 1999
Recombinant allergens for specific immunotherapyR Valenta, S Vrtala
Allergy|August 5, 1998
Recombinant allergensR Valenta, S Vrtala, S Laffer, et al.
Allergy|September 4, 2013
An assay that may predict the development of IgG enhancing allergen-specific IgE binding during birch immunotherapyR Selb, J Eckl-Dorna, S Vrtala, et al.
Allergy|February 14, 2008
From allergen genes to new forms of allergy diagnosis and treatmentS Vrtala
Allergy|January 18, 2006
The role of Foxp3+ T cells in long-term efficacy of prophylactic and therapeutic mucosal tolerance induction in miceB Winkler, K Hufnagl, A Spittler, et al.
Allergy|July 26, 2017
House dust mites as potential carriers for IgE sensitization to bacterial antigensS Dzoro, I Mittermann, Y Resch-Marat, et al.
Allergy|August 14, 2002
Recombinant allergen-based concepts for diagnosis and therapy of type I allergyR Valenta
Allergy|January 11, 2018
Similar localization of conformational IgE epitopes on the house dust mite allergens Der p 5 and Der p 21 despite limited IgE cross-reactivityM Curin, T Garmatiuk, Y Resch-Marat, et al.
Allergy|February 21, 2012
Carrier-bound nonallergenic Der p 2 peptides induce IgG antibodies blocking allergen-induced basophil activation in allergic patientsK-W Chen, M Focke-Tejkl, K Blatt, et al.
Allergy|January 10, 2018
Isolation of a high-affinity Bet v 1-specific IgG-derived ScFv from a subject vaccinated with hypoallergenic Bet v 1 fragmentsE Gadermaier, K Marth, C Lupinek, et al.
Pageof 6